abstract |
The invention relates to novel tetrahydroquinoline derivatives, a process for their preparation, their use either alone or in combination for the treatment and / or prevention of disease, in addition to their use for the preparation of drugs, in particular as an inhibitor of the cholesterol ester transfer protein (CETP) for treatment and / or prevention of cardiovascular diseases, especially hypolipoproteinemia, dyslipidemia, hypertriglyceridemia, hyperlipidemia, hypercholesterolemia and atherosclerosis. |